(12) Patent Application Publication (10) Pub. No.: US 2004/0120901 A1 Wu Et Al

Total Page:16

File Type:pdf, Size:1020Kb

(12) Patent Application Publication (10) Pub. No.: US 2004/0120901 A1 Wu Et Al US 20040120901A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0120901 A1 Wu et al. (43) Pub. Date: Jun. 24, 2004 (54) DENTAL COMPOSITIONS INCLUDING (22) Filed: Dec. 20, 2002 ENZYMES AND METHODS Publication Classification (76) Inventors: Dong Wu, Woodbury, MN (US); Joel D. Oxman, Minneapolis, MN (US); (51) Int. Cl." ............................... A61K 7/28: A61C 5/00 Sumita B. Mitra, West St. Paul, MN (52) U.S. Cl. ........................................... 424/50; 433/217.1 (US); Ingo Reinhold Haberlein, Weilheim (DE) (57) ABSTRACT A hardenable dental composition that includes a polymer Correspondence Address: izable component and a therapeutic enzyme mixed within 3M INNOVATIVE PROPERTIES COMPANY the polymerizable component, wherein upon hardening the PO BOX 33427 polymerizable component to form a hardened dental mate ST. PAUL, MN 55133-3427 (US) rial having a therapeutic enzyme mixed therein, the hard ened dental material with the enzyme mixed therein is in (21) Appl. No.: 10/327,411 contact with Saliva in a Subject's mouth for at least 1 day. US 2004/O120901 A1 Jun. 24, 2004 DENTAL COMPOSITIONS INCLUDING ENZYMES form a hardened dental material having a therapeutic AND METHODS enzyme mixed therein, the hardened dental material with the enzyme mixed therein is in contact with Saliva in a Subject's BACKGROUND mouth for at least 1 day; wherein the therapeutic enzyme is Selected from the group consisting of oxidases, peroxidases, 0001 Enzymes have been used in products for the laccases, proteases, carbohydrases, lipases, and combina improvement of oral health. Such products include, for tions thereof, and wherein the polymerizable component is example, mouthwashes, toothpastes, dentrifices, and the Selected from the group consisting of (meth)acrylates, like. For example, the enzyme glucose oxidase has been (meth)acrylamides, and combinations thereof. used in mouthwash products to reduce halitosis. Also, a plaque hydrolyzing enzyme called DXAMase is proposed 0007. The present invention also provides methods. In for use in toothpastes and mouthwashes. Enzymes have also one embodiment, the present invention provides a method of been proposed for use in a microStructured delivery device delivering a therapeutic enzyme to a Subject's mouth to for the oral environment. improve the oral health of the subject. The method includes: providing a hardenable dental composition that includes a 0002 These products are used for short periods of time polymerizable component and a therapeutic enzyme mixed (e.g., often for minutes or hours, and generally for less than within the polymerizable component, placing the hardenable one day) and are treated as disposables and discarded after dental composition in the mouth of the Subject; and hard each application. Thus, what is needed are compositions that ening the composition to form a hardened dental material include enzymes that can provide a desirable effect over an having a therapeutic enzyme mixed therein, the hardened extended period of time. material with the enzyme mixed therein is in contact with Saliva in a Subject's mouth for at least 1 day. SUMMARY 0003. The present invention is directed toward composi DETAILED DESCRIPTION OF PREFERRED tions containing enzymes and polymerizable components EMBODIMENTS that can be used in a variety of dental applications. Such 0008. The present invention is directed toward composi compositions are particularly useful for providing contact tions containing enzymes and polymerizable components between Saliva in a patient's mouth and an enzyme over an that can be used in a variety of dental applications. Such extended period of time. The enzyme is blended into the compositions are particularly useful for providing a thera composition and upon hardening is mixed throughout the peutic enzyme to the Surface of a hardened dental material hardened material and is available at the Surface of the over an extended period of time. These compositions can be hardened material. These compositions can be used in used in methods and kits for improving the oral health of a methods and for improving the oral health of a Subject Subject having the dental material incorporated into their having the dental material incorporated into their mouth for mouth Such that the hardened dental material with the an extended period of time. enzyme mixed therein is in contact with Saliva in a patient's 0004 More specifically, the present invention provides a mouth for an extended period of time (e.g., for at least 1 day, dental composition that includes a polymerizable compo alternatively at least 7 days, and typically much longer Such nent and a therapeutic enzyme mixed within the polymer as at least 30 days, and often at least 90 days). izable component, wherein upon hardening the polymeriZ 0009. The hardened dental material can be any of a wide able component to form a hardened dental material having variety of materials that are prepared from polymerizable a therapeutic enzyme mixed therein, the hardened dental materials. Preferably, however, the hardened dental material material with the enzyme mixed therein is in contact with is not a Surface pre-treatment material (e.g., etchant, primer, Saliva in a Subject's mouth for at least 1 day (preferably, for bonding agent). Rather, preferably, the hardened dental at least 7 days). material is a restorative (e.g., composite, filling material or 0005. In a preferred embodiment, the present invention prosthesis), Sealant, coating, cement, or orthodontic adhe provides a hardenable dental composition that includes a SVC. polymerizable component and a therapeutic enzyme mixed 0010 Thus, the present invention provides materials that within the polymerizable component; wherein upon hard can preferably provide extended contact between the ening the polymerizable component to form a hardened enzyme and the environment of the mouth. Enzymes that dental material having a therapeutic enzyme mixed therein, remain biologically active over the contact time (or for a the hardened dental material with the enzyme mixed therein Significant portion thereof) are particularly desirable. That is in contact with Saliva in a Subject's mouth for at least 1 is, preferably, the present invention provides an enzyme day, wherein the therapeutic enzyme is Selected from the mixed within a hardened material that is available for group consisting of an oxidoreductase, a hydrolase, and reaction with an enzyme substrate (whether it be in the combinations thereof, and wherein the polymerizable com mouth and/or provided in the hardened material itself) to ponent is Selected from the group consisting of epoxy resins, provide beneficial results. Prior to the present invention it Vinyl ether resins, ethylenically unsaturated compounds, was unexpected that an enzyme could be incorporated into glass ionomer cements, and combinations thereof. a hardenable dental composition, which upon hardening 0006. In another preferred embodiment, the present provides exposure of the enzyme to the oral environment for invention provides a hardenable dental composition that an extended period of time. includes a polymerizable component and a therapeutic 0011 Such compositions can prove to be very valuable enzyme mixed within the polymerizable component; and beneficial compositions for dental care. Typically, the wherein upon hardening the polymerizable component to use of enzymes instead of chemicals can be leSS harmful to US 2004/O120901 A1 Jun. 24, 2004 a patient's health and cause fewer Side effects. This is ecules. The donor molecules are typically capable of acting particularly true for the prevention of dental plaque, which as a Substrate for the peroxidase in generating Such free contributes to dental tooth and gum diseases. Enzymes radicals. Examples include, but are not limited to, horserad useful in the practice of this invention are therapeutic ish peroxidase, Soybean peroxidase, polyphenol peroxidase, enzymes, which herein means that they cause (e.g., by manganese peroxidase, L-ascorbate peroxidase, chloroper catalysis) the decomposition of harmful carbohydrates, pro oxidase, and iodide peroxidase. Corresponding enzyme Sub teins, lipids, and/or bacterial Substrates in the mouth of a Strates include, but are not limited to, hydrogen peroxide and Subject (e.g., in the oral plaque and Saliva). A preferred electron donor molecules Such as polyphenol, manganese group of enzymes generate bactericidal products (e.g., (II), ascorbic acid, chloride, and iodide. H2O). 0018 Laccase enzymes act on O and yield water without 0012 Optionally, one or more enzyme substrates can be any need for peroxide. These include enzymes classified added to the compositions of the present invention to under the enzyme classification E.C. 1.10.3. Corresponding enhance the therapeutic function of the enzymes. For Substrates include, but are not limited to, O- and P-quinols, example, for Systems requiring water for activation, an aminophenols, and phenylenediamine. enzyme Substrate could be present in the composition with the enzymes if the System is anhydrous until use, thereby 0019 Hydrolase enzymes are those classified under the keeping the enzymes and Substrate from interacting. Alter Enzyme Classification number E.C. 3 in accordance with the natively, the enzymes and corresponding enzyme Substrates Recommendations (1992) of the International Union of Biochemistry and Molecular Biology (IUBMB). Within the can be packaged in Separate parts of a kit to keep them from group of hydrolase
Recommended publications
  • Substrate Specificities of Outer Membrane Proteases of the Omptin Family in Escherichia Coli, Salmonella Enterica, and Citrobacter Rodentium
    Substrate specificities of outer membrane proteases of the omptin family in Escherichia coli, Salmonella enterica, and Citrobacter rodentium Andrea Portt, McGill University, Montreal October 9th, 2010 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master’s in Microbiology © Andrea Portt 2010 Table of Contents LIST OF ABBREVIATIONS 3 ABSTRACT 6 ACKNOWLEDGEMENTS 7 CONTRIBUTIONS OF AUTHORS 8 LITERATURE REVIEW 9 2. OMPTINS 9 3. OMPTIN SUBSTRATES 13 A. ANTIMICROBIAL PEPTIDES 13 B. BLOOD CLOTTING PROTEINS AND EXTRACELLULAR MATRIX 14 C. COMPLEMENT 16 D. TROPOMYOSIN 17 4. EVOLUTION OF OMPTINS 17 5. OMPTIN REGULATION 20 6. OMPTINS OF PATHOGENIC ENTEROBACTEREACEAE 22 A. Y. PESTIS 22 B. S. ENTERICA 23 C. SHIGELLA 25 D. ATTACHING AND EFFACING BACTERIA 25 INTRODUCTION 28 MATERIALS AND METHODS 29 1. BACTERIAL GROWTH 29 2. BACTERIAL STRAINS AND CONSTRUCTION OF PLASMIDS 29 A. STRAINS 29 B. PLASMIDS 31 3. DISK INHIBITION ASSAYS 34 4. MINIMUM INHIBITORY CONCENTRATION DETERMINATIONS 34 5. PROTEOLYTIC CLEAVAGE OF AMPS BY CELLS EXPRESSING OMPTINS 34 6. OM DISRUPTION ASSAY WITH 1-N-PHENYLNAPHTHYLAMINE 35 7. DEGRADATION OF TROPOMYOSIN BY E. COLI AND C. RODENTIUM STRAINS EXPRESSING OMPTINS 35 8. REAL-TIME QUANTITATIVE PCR 35 9. PURIFICATION OF NATIVE CROP 35 10. EXPRESSION, PURIFICATION, AND REFOLDING OF HIS-PGTE AND HIS-CROP 36 A. EXPRESSION 36 B. PURIFICATION 36 C. REFOLDING 36 11. CLEAVAGE OF C2 FRET SUBSTRATE BY WHOLE CELLS OR PURIFIED OMPTINS 37 A. WHOLE CELLS 37 B. PURIFIED OMPTINS 37 1 RESULTS 38 1. GROWTH INHIBITION OF E. COLI AND C. RODENTIUM STRAINS EXPRESSING OMPTINS BY C18G.
    [Show full text]
  • Functional Characterization of Extracellular Protease Inhibitors of Phytophthora Spp and Their Targets Tomato Proteases
    FUNCTIONAL CHARACTERIZATION OF EXTRACELLULAR PROTEASE INHIBITORS OF PHYTOPHTHORA SPP AND THEIR TARGETS TOMATO PROTEASES DISSERTATION Presented in Partial Fulfillment of the Requirements for The Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Jing Song, M.S. * * * * The Ohio State University 2007 Dissertation Committee: Dr. Sophien Kamoun, Adviser Approved by Dr. Anne E. Dorrance Dr. Terrence L. Graham Adviser Dr. Margaret G. Redinbaugh ______________________ Dr. Eric J. Stockinger Graduate Program in Plant Pathology ABSTRACT The interplay between proteases and protease inhibitors during plant- pathogen interaction represents a common strategy for defense and counter- defense. The plant pathogens Phytophthora infestans and Phytophthora mirabilis secrete effectors such as protease inhibitors that facilitate host colonization through a defense-counterdefense mechanism. The P. infestans serine protease inhibitors EPI1 and EPI10 physically bind and inhibit the tomato serine protease P69B. On the other hand, the P. infestans cysteine protease inhibitor EPIC2B targets PIP1, a papain-like protease that has close similarity to another tomato cysteine protease Rcr3, which is required for the fungal resistance and Avr2 hypersensitivity in Cf-2 tomato. The objective of this research is to characterize these protease inhibitors and their association with specific targets in the host. We studied the structure and activities of these protease inhibitors and their target proteases using recombinant proteins expressed in Escherichia coli and Nicotiana benthamiana. PIP1-His was pulled down using coimmunoprecipitation with anti-FLAG resin from N. benthamiana apoplast by recombinant protein FLAG-EPIC2B, suggesting physical interaction of EPIC2B and PIP1. Similarly, tomato protease Rcr3pim was shown to be a common target for both the ii Cladosporium fulvum effector Avr2 and P.
    [Show full text]
  • Progress in the Field of Aspartic Proteinases in Cheese Manufacturing
    Progress in the field of aspartic proteinases in cheese manufacturing: structures, functions, catalytic mechanism, inhibition, and engineering Sirma Yegin, Peter Dekker To cite this version: Sirma Yegin, Peter Dekker. Progress in the field of aspartic proteinases in cheese manufacturing: structures, functions, catalytic mechanism, inhibition, and engineering. Dairy Science & Technology, EDP sciences/Springer, 2013, 93 (6), pp.565-594. 10.1007/s13594-013-0137-2. hal-01201447 HAL Id: hal-01201447 https://hal.archives-ouvertes.fr/hal-01201447 Submitted on 17 Sep 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Dairy Sci. & Technol. (2013) 93:565–594 DOI 10.1007/s13594-013-0137-2 REVIEW PAPER Progress in the field of aspartic proteinases in cheese manufacturing: structures, functions, catalytic mechanism, inhibition, and engineering Sirma Yegin & Peter Dekker Received: 25 February 2013 /Revised: 16 May 2013 /Accepted: 21 May 2013 / Published online: 27 June 2013 # INRA and Springer-Verlag France 2013 Abstract Aspartic proteinases are an important class of proteinases which are widely used as milk-coagulating agents in industrial cheese production. They are available from a wide range of sources including mammals, plants, and microorganisms.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • De¢Cient Strains of the Methylotrophic Yeast Ogataea Minuta
    RESEARCH ARTICLE Antibody expression in protease-de¢cient strains ofthe methylotrophic yeast Ogataea minuta Kousuke Kuroda1,2, Yoshinori Kitagawa1, Kazuo Kobayashi1, Haruhiko Tsumura1, Toshihiro Komeda3, Eiji Mori4, Kazuhiro Motoki4, Shiro Kataoka4, Yasunori Chiba5 & Yoshifumi Jigami2,5 1Kirin Brewery Co. Ltd, CMC R&D Laboratories, Gunma, Japan; 2Graduate School of Life and Environmental Science, University of Tsukuba, Ibaraki, Japan; 3Kirin Brewery Co. Ltd, Central Laboratories for Frontier Technology, Kanagawa, Japan; 4Kirin Brewery Co. Ltd, Pharmaceutical Research Laboratories, Gunma, Japan; and 5National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, Japan Downloaded from https://academic.oup.com/femsyr/article/7/8/1307/549124 by guest on 27 September 2021 Correspondence: Yoshifumi Jigami, National Abstract Institute of Advanced Industrial Science and Technology (AIST), Ibaraki 305-8566, Japan. When human antibody genes were expressed in the methylotrophic yeast Ogataea Tel.: 181 29 861 6160; fax: 181 29 861 minuta, the secreted antibody became partially degraded. To suppress the 6161; e-mail: [email protected] degradation, a vacuolar protease-deficient strain was constructed and its antibody production was evaluated. Although antibody productivity was improved in the Received 28 February 2007; revised 28 May vacuolar protease-deficient strain, the secreted antibody still became partially 2007; accepted 16 June 2007. degraded. Peptide sequencing revealed that the cleavage occurred in the CH1 First published online 23 August 2007. region of the heavy chain, implying that the cleavage was caused by an aspartic protease, Yps1p. To inhibit this cleavage, Yps1p-deficient strains were constructed DOI:10.1111/j.1567-1364.2007.00291.x and their antibody production was evaluated.
    [Show full text]
  • Proteolytic Enzymes in Grass Pollen and Their Relationship to Allergenic Proteins
    Proteolytic Enzymes in Grass Pollen and their Relationship to Allergenic Proteins By Rohit G. Saldanha A thesis submitted in fulfilment of the requirements for the degree of Masters by Research Faculty of Medicine The University of New South Wales March 2005 TABLE OF CONTENTS TABLE OF CONTENTS 1 LIST OF FIGURES 6 LIST OF TABLES 8 LIST OF TABLES 8 ABBREVIATIONS 8 ACKNOWLEDGEMENTS 11 PUBLISHED WORK FROM THIS THESIS 12 ABSTRACT 13 1. ASTHMA AND SENSITISATION IN ALLERGIC DISEASES 14 1.1 Defining Asthma and its Clinical Presentation 14 1.2 Inflammatory Responses in Asthma 15 1.2.1 The Early Phase Response 15 1.2.2 The Late Phase Reaction 16 1.3 Effects of Airway Inflammation 16 1.3.1 Respiratory Epithelium 16 1.3.2 Airway Remodelling 17 1.4 Classification of Asthma 18 1.4.1 Extrinsic Asthma 19 1.4.2 Intrinsic Asthma 19 1.5 Prevalence of Asthma 20 1.6 Immunological Sensitisation 22 1.7 Antigen Presentation and development of T cell Responses. 22 1.8 Factors Influencing T cell Activation Responses 25 1.8.1 Co-Stimulatory Interactions 25 1.8.2 Cognate Cellular Interactions 26 1.8.3 Soluble Pro-inflammatory Factors 26 1.9 Intracellular Signalling Mechanisms Regulating T cell Differentiation 30 2 POLLEN ALLERGENS AND THEIR RELATIONSHIP TO PROTEOLYTIC ENZYMES 33 1 2.1 The Role of Pollen Allergens in Asthma 33 2.2 Environmental Factors influencing Pollen Exposure 33 2.3 Classification of Pollen Sources 35 2.3.1 Taxonomy of Pollen Sources 35 2.3.2 Cross-Reactivity between different Pollen Allergens 40 2.4 Classification of Pollen Allergens 41 2.4.1
    [Show full text]
  • Review Article the Role of Microbial Aspartic Protease Enzyme in Food and Beverage Industries
    Hindawi Journal of Food Quality Volume 2018, Article ID 7957269, 15 pages https://doi.org/10.1155/2018/7957269 Review Article The Role of Microbial Aspartic Protease Enzyme in Food and Beverage Industries Jermen Mamo and Fassil Assefa Microbial, Cellular and Molecular Biology Department, College of Natural Science, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia Correspondence should be addressed to Jermen Mamo; [email protected] Received 3 April 2018; Revised 16 May 2018; Accepted 29 May 2018; Published 3 July 2018 Academic Editor: Antimo Di Maro Copyright © 2018 Jermen Mamo and Fassil Assefa. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Proteases represent one of the three largest groups of industrial enzymes and account for about 60% of the total global enzymes sale. According to the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology, proteases are classied in enzymes of class 3, the hydrolases, and the subclass 3.4, the peptide hydrolases or peptidase. Proteases are generally grouped into two main classes based on their site of action, that is, exopeptidases and endopeptidases. Protease has also been grouped into four classes based on their catalytic action: aspartic, cysteine, metallo, and serine proteases. However, lately, three new systems have been dened: the threonine-based proteasome system, the glutamate-glutamine system of eqolisin, and the serine-glutamate-aspartate system of sedolisin. Aspartic proteases (EC 3.4.23) are peptidases that display various activities and specicities.
    [Show full text]
  • Wo 2011/089170 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . _ 28 July 2011 (28.07.2011) WO 2011/089170 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07K 14/50 (2006.01) A61K 47/48 (2006.01) kind of national protection available): AE, AG, AL, AM, C12P 21/00 (2006.01) A61P 3/04 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, A61K 38/18 (2006.01) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (21) International Application Number: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, PCT/EP201 1/050718 KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (22) International Filing Date: ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, 20 January 20 11 (20.0 1.20 11) NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (25) Filing Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 12/692,227 22 January 2010 (22.01 .2010) U S GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, PCT/EP20 10/050720 ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, 22 January 2010 (22.01 .2010) EP TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 10165927.4 15 June 2010 (15.06.2010) EP EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, 61/356,086 18 June 2010 (18.06.2010) U S LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, (71) Applicant (for all designated States except US): NOVO GW, ML, MR, NE, SN, TD, TG).
    [Show full text]
  • Structure Prediction of Outer Membrane Protease Protein of Salmonella Typhimurium Using Computational Techniques
    INT. J. BIOAUTOMATION, 2016, 20(1), 5-18 Structure Prediction of Outer Membrane Protease Protein of Salmonella typhimurium Using Computational Techniques Rozina Tabassum*, Muhammad Haseeb, Sahar Fazal Department of Bioinformatics and Biosciences Mohammad Ali Jinnah University Islamabad, Pakistan E-mails: [email protected], [email protected], [email protected] *Corresponding author Received: April 04, 2015 Accepted: November 16, 2015 Published: March 31, 2016 Abstract: Salmonella typhimurium, a facultative gram-negative intracellular pathogen belonging to family Enterobacteriaceae, is the most frequent cause of human gastroenteritis worldwide. PgtE gene product,outer membrane protease emerges important in the intracellular phases of salmonellosis. The pgtE gene product of S. typhimurium was predicted to be capable of proteolyzing T7 RNA polymerase and localize in the outer membrane of these gram negative bacteria. PgtE product of S. enterica and OmpT of E. coli, having high sequence similarity have been revealed to degrade macrophages, causing salmonellosis and other diseases. The three-dimensional structure of the protein was not available through Protein Data Bank (PDB) creating lack of structural information about E protein. In our study, by performing Comparative model building, the three dimensional structure of outer membrane protease protein was generated using the backbone of the crystal structure of Pla of Yersinia pestis, retrieved from PDB, with MODELLER (9v8). Quality of the model was assessed by validation tool PROCHECK, web servers like ERRAT and ProSA are used to certify the reliability of the predicted model. This information might offer clues for better understanding of E protein and consequently for developmet of better therapeutic treatment against pathogenic role of this protein in salmonellosis and other diseases.
    [Show full text]
  • New Human Aspartic Proteinases
    View metadata,FEBS 21271 citation and similar papers at core.ac.uk FEBS Letters 441brought (1998) to you 43^48 by CORE provided by Elsevier - Publisher Connector Napsins: new human aspartic proteinases Distinction between two closely related genes Peter J. Tatnell1;a, David J. Powell1;b, Je¡rey Hilla, Trudi S. Smithb, David G. Tewb, John Kaya;* aSchool of Biosciences, Cardi¡ University, P.O. Box 911, Cardi¡ CF1 3US, UK bSmithKline Beecham Pharmaceuticals, 709 Swedeland Rd, King of Prussia, PA 19406, USA Received 27 October 1998 [6]. With the advent of human genome projects, ready access Abstract cDNA sequences were elucidated for two closely related human genes which encode the precursors of two hitherto to a vast array of human expressed sequence tags (ESTs) is unknown aspartic proteinases. The (pro)napsin A gene is now possible. Interrogation of these databases for the hall- expressed predominantly in lung and kidney and its translation mark sequences of aspartic proteinases, i.e. the VHydro- product is predicted to be a fully functional, glycosylated aspartic phobic-Hydrophobic-Asp-Thr/Ser-GlyV plus VHydropho- proteinase (precursor) containing an RGD motif and an bic-Hydrophobic-GlyV motifs, gave a preliminary additional 18 residues at its C-terminus. The (pro)napsin B indication that yet further aspartic proteinases were encoded gene is transcribed exclusively in cells related to the immune within the human genome. We have called these napsins (for system but lacks an in-frame stop codon and contains a number novel aspartic proteinases of the pepsin family). of polymorphisms, one of which replaces a catalytically crucial Gly residue with an Arg.
    [Show full text]
  • DUAL ROLE of CATHEPSIN D: LIGAND and PROTEASE Martin Fuseka, Václav Větvičkab
    Biomed. Papers 149(1), 43–50 (2005) 43 © M. Fusek, V. Větvička DUAL ROLE OF CATHEPSIN D: LIGAND AND PROTEASE Martin Fuseka, Václav Větvičkab* a Institute of Organic Chemistry and Biochemistry, CAS, Prague, Czech Republic, and b University of Louisville, Department of Pathology, Louisville, KY40292, USA, e-mail: [email protected] Received: April 15, 2005; Accepted (with revisions): June 20, 2005 Key words: Cathepsin D/Procathepsin D/Cancer/Activation peptide/Mitogenic activity/Proliferation Cathepsin D is peptidase belonging to the family of aspartic peptidases. Its mostly described function is intracel- lular catabolism in lysosomal compartments, other physiological effect include hormone and antigen processing. For almost two decades, there have been an increasing number of data describing additional roles imparted by cathepsin D and its pro-enzyme, resulting in cathepsin D being a specific biomarker of some diseases. These roles in pathological conditions, namely elevated levels in certain tumor tissues, seem to be connected to another, yet not fully understood functionality. However, despite numerous studies, the mechanisms of cathepsin D and its precursor’s actions are still not completely understood. From results discussed in this article it might be concluded that cathepsin D in its zymogen status has additional function, which is rather dependent on a “ligand-like” function then on proteolytic activity. CATHEPSIN D – MEMBER PRIMARY, SECONDARY AND TERTIARY OF ASPARTIC PEPTIDASES FAMILY STRUCTURES OF ASPARTIC PEPTIDASES Major function of cathepsin D is the digestion of There is a high degree of sequence similarity among proteins and peptides within the acidic compartment eukaryotic members of the family of aspartic peptidases, of lysosome1.
    [Show full text]
  • The Complete Amino Acid Sequence of Prochymosin
    Proc. Natl. Acad. Sci. USA Vol. 74, No. 6, pp. 2321-2324, June 1977 Biochemistry The complete amino acid sequence of prochymosin (protease/primary structure/homology) BENT FOLTMANN, VIBEKE BARKHOLT PEDERSEN, HENNING JACOBSEN*, DOROTHY KAUFFMANt, AND GRITH WYBRANDTf Institute of Biochemical Genetics, University of Copenhagen, 0. Farimagsgade 2A, DK-1353 Copenhagen K, Denmark Communicated by Hans Neurath, March 18,1977 ABSTRACT The total sequence of 365 amino acid residues order to avoid unspecific, chymotrypsin-like cleavages (13). in bovine prochymosin is presented. Alignment with the amino After such treatment the large fragments were purified by gel acid sequence of porcine pepsinogen shows that 204 amino acid with residues are common to the two zymogens. Further comparison filtration on Sephadex G-100 in 0.05 M NH4HCO3, pH 8, and alignment with the amino acid sequence of penicillopepsin 8 M urea. After cleavage of chymosin with cyanogen bromide shows that 66 residues are located at identical positions in all the fragments were purified by gel filtration on Sephadex G-100 three proteases. The three enzymes belong to a large group of in 25% acetic acid. The best results were obtained if cleavage proteases with two aspartate residues in the active center. This was performed on enzyme with intact disulfide bridges. By such group forms a family derived from one common ancestor. treatment two of the large fragments, CB(211-302) and CB(314-373), are held together and separated from the frag- Chymosin (EC 3.4.23.4) is the major proteolytic enzyme in the ment next in size, CB(45-126).
    [Show full text]